Paul Whitaker

Queen's University Belfast — United Kingdom

Medicine · Health Sciences

33h-index3.9kcitations179works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(49), Drug-Induced Adverse Reactions(47), Asthma and respiratory diseases(18), Neonatal Respiratory Health Research(15), Respiratory viral infections research(12)

Publications169 total

Correction: A social prescribing model for tackling the health and social inequalities of people living with severe mental illness: a protocol paper
BMC Public Health·2025Open Access
Phenotypic and functional characterisation of liver-infiltrating T-cells in a case of CFTR modulator induced drug-induced liver injury
Journal of Cystic Fibrosis·2025Open Access
Publisher Correction: A practical guide to the diagnosis and management of suspected Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom
npj Primary Care Respiratory Medicine·2025Open Access
Author Correction: A practical guide to the diagnosis and management of suspected Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom
npj Primary Care Respiratory Medicine·2025Open Access
Future Island-Island Impact Cards
Research Portal (King's College London)·2025Open Access
A practical guide to the diagnosis and management of suspected Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom
npj Primary Care Respiratory Medicine·2024· 12 citedOpen Access
Prospective Piperacillin Lymphocyte Transformation Testing in Patients With Cystic Fibrosis Receiving Regular and Desensitization Courses of Piperacillin-Tazobactam
The Journal of Allergy and Clinical Immunology In Practice·2024Open Access
Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients
Chemical Research in Toxicology·2022· 4 citedOpen Access
Editorial: Drug allergy
Current Opinion in Allergy and Clinical Immunology·2022
Musculoskeletal tuberculosis in Bradford
Bone & Joint Open·2022· 4 citedOpen Access
Editorial: Advances in drug hypersensitivity reactions
Current Opinion in Allergy and Clinical Immunology·2021
Cell Membrane Transporters Facilitate the Accumulation of Hepatocellular Flucloxacillin Protein Adducts: Implication in Flucloxacillin-Induced Liver Injury
Chemical Research in Toxicology·2020· 9 cited
Noninvasive Ventilation in Cystic Fibrosis: Clinical Indications and Outcomes in a Large UK Adult Cystic Fibrosis Center
Respiratory Care·2020· 8 citedOpen Access
Identification of Flucloxacillin-Haptenated HLA-B*57:01 Ligands: Evidence of Antigen Processing and Presentation
Toxicological Sciences·2020· 31 citedOpen Access
Editorial: Advances in hypersensitivity drug reactions
Current Opinion in Allergy and Clinical Immunology·2020· 1 cited
Ţintind un diagnostic mai precis în hipersensibilitatea la betalactamine
Alergologia·2020
WS12.6 Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
Journal of Cystic Fibrosis·2020Open Access
Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK
BMJ Open Respiratory Research·2020· 33 citedOpen Access
Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
eLife·2020· 101 citedOpen Access
Author response: Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
2020Open Access
page 1 of 9Next →

Frequent Co-authors

D. Peckham(23), Dean J. Naisbitt(18), Xiaoli Meng(11), John Farrell(8), Rosalind E. Jenkins(7), C. Etherington(6), I. Clifton(5), Neil French(5), Antonino Romano(4), Knut Brockow(4), Pascal Demoly(4), Sabah H. El-Ghaiesh(4), Manal Monshi(4), Munir Pirmohamed(4), Jean‐Christoph Caubet(3), Gülfem Çelík(3), Alla Nakonechna(3), Marı́a José Torres(3), Sidonie N. Lavergne(3), Caroline J. Earnshaw(3)